Procter & Gamble Health Board Meeting Outcome

Procter & Gamble Health Results Update

P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.

Procter & Gamble Health Q2 FY27 Results: Net Profit ₹111.5 Cr, Up 26.0% YoY

Procter & Gamble Health Ltd reported revenue from operations of ₹382.5 Cr (+17.7% YoY) and net profit of ₹111.5 Cr (+26.0% YoY) for Q2 FY27.

Key figure

Net profit ₹111.5 Cr · +26.0% YoY

Procter & Gamble Health Board Meeting Date

Procter & Gamble Health Limited will hold a board meeting on November 2, 2026, to consider and approve the unaudited financial results for the quarter ending September 30, 2026.

Procter & Gamble Health Other Announcement

Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.

Procter & Gamble Health Management Change

Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.

Execution

5 years

Procter & Gamble Health Annual General Meeting

Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.

Shri Keshav Cements & Infra Board Meeting Outcome

Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.

Balmer Lawrie Investments Board Meeting Outcome

Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.

Execution

FY 2026-27

Jiwanram Sheoduttrai Industries Board Meeting Outcome

Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.

Finolex Cables Board Meeting Outcome

Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).

Chatterbox Technologies Board Meeting Outcome

Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.

BCC Fuba India Board Meeting Outcome

BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.